Jacob Quint

Papers

Total Citations

114

H-Index

About

Dr. Jacob Quint is pioneering the frontier of regenerative medicine through *in vivo* bioprinting, a transformative approach that fabricates tissue-engineered implants directly within a patient’s body during surgery. His key research centers on developing robotic systems and biomaterials that enable intraoperative scaffold printing, bypassing the logistical delays and static designs of traditional bioprinting. Quint’s landmark 2022 paper, “In situ bioprinting: intraoperative implementation of regenerative medicine,” has garnered 109 citations, establishing a foundational framework for this emerging field. He further advanced the technology with his 2024 work on an open-source robotic arm for patient-specific scaffold creation, demonstrating real-time reconstructive adjustments that minimize transportation and treatment time. By integrating robotics with regenerative biology, Quint’s contributions promise to revolutionize personalized surgical reconstruction, offering immediate, adaptive solutions for complex tissue defects. His open-source ethos accelerates clinical translation, making sophisticated bioprinting accessible to broader research communities. For students and researchers, Quint’s work exemplifies how engineering and medicine converge to solve pressing clinical challenges, with his high-impact citations reflecting a rapidly growing influence in regenerative surgery.